FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.372
EU - Europa 15.436
AS - Asia 5.045
SA - Sud America 187
AF - Africa 73
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 24
Totale 46.170
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.279
GB - Regno Unito 5.864
IT - Italia 3.878
SE - Svezia 1.870
CN - Cina 1.535
SG - Singapore 1.283
HK - Hong Kong 977
DE - Germania 939
TR - Turchia 732
UA - Ucraina 728
FI - Finlandia 448
RU - Federazione Russa 367
FR - Francia 349
BG - Bulgaria 301
RO - Romania 135
IN - India 119
BR - Brasile 112
IE - Irlanda 105
NL - Olanda 89
BE - Belgio 84
KR - Corea 66
CA - Canada 55
CH - Svizzera 47
ID - Indonesia 44
TH - Thailandia 42
IR - Iran 41
MY - Malesia 40
JP - Giappone 39
ES - Italia 36
LT - Lituania 32
PL - Polonia 32
VN - Vietnam 29
AU - Australia 28
MX - Messico 25
PT - Portogallo 25
CZ - Repubblica Ceca 23
CL - Cile 22
EU - Europa 20
IL - Israele 17
DZ - Algeria 16
GR - Grecia 16
IQ - Iraq 15
TW - Taiwan 14
MA - Marocco 13
MD - Moldavia 13
PE - Perù 13
ZA - Sudafrica 13
CO - Colombia 12
EC - Ecuador 12
EG - Egitto 12
PK - Pakistan 12
AR - Argentina 10
AT - Austria 9
DK - Danimarca 7
HU - Ungheria 7
SN - Senegal 7
NO - Norvegia 6
AL - Albania 5
AZ - Azerbaigian 5
BY - Bielorussia 5
NZ - Nuova Zelanda 5
AE - Emirati Arabi Uniti 4
BZ - Belize 4
PH - Filippine 4
RS - Serbia 4
SI - Slovenia 4
YE - Yemen 4
KZ - Kazakistan 3
LK - Sri Lanka 3
SA - Arabia Saudita 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AN - Antille olandesi 2
BD - Bangladesh 2
CD - Congo 2
CR - Costa Rica 2
JM - Giamaica 2
LV - Lettonia 2
MG - Madagascar 2
NG - Nigeria 2
TN - Tunisia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GL - Groenlandia 1
GT - Guatemala 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MK - Macedonia 1
MM - Myanmar 1
Totale 46.160
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Santa Clara 3.232
Fairfield 2.615
Chandler 2.171
Woodbridge 1.903
Ashburn 1.709
Jacksonville 1.613
Houston 1.282
Dearborn 1.214
Nyköping 1.060
Seattle 1.052
Ann Arbor 1.049
Wilmington 1.043
Hong Kong 963
Singapore 901
Cambridge 871
Modena 477
Izmir 461
Beijing 446
Princeton 324
Sofia 297
Eugene 275
Chicago 238
San Diego 234
Des Moines 232
Milan 227
Helsinki 185
Redwood City 180
New York 156
Rome 156
Bremen 145
Moscow 109
London 107
Fremont 104
Dublin 89
Boardman 88
Shanghai 79
Brussels 78
Falls Church 76
Bologna 74
Naples 60
Hefei 54
Norwalk 54
Parma 53
Guangzhou 50
Los Angeles 50
Como 49
Florence 49
Kunming 44
Munich 40
Turin 40
Nanjing 39
Napoli 39
Jakarta 36
Frankfurt am Main 33
Reggio Emilia 33
Bari 31
Tulare 31
Verona 30
Palermo 29
San Mateo 29
Jinan 28
Catania 26
San Giuliano Milanese 26
Ferrara 25
Indiana 25
Mountain View 24
Milwaukee 23
Dallas 22
Auburn Hills 19
Hangzhou 19
Hounslow 19
Toronto 19
Wuhan 19
Augusta 18
Genoa 18
Washington 18
Kocaeli 17
Perugia 17
Philadelphia 17
Grafing 16
Leawood 16
Istanbul 15
Kilburn 15
Phoenix 15
Brescia 14
Hanoi 14
Saint Petersburg 14
São Paulo 14
Tokyo 14
Zhengzhou 14
Chengdu 13
Chisinau 13
Dong Ket 13
Nanchang 13
Paris 13
Ardabil 12
Brno 12
Carmichael 12
Chiswick 12
Totale 34.281
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 405
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 397
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 351
Cristallinità ed equivalenza nel cloramfenicolo palmitato 316
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 313
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 308
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 294
NUTRASCIENCE s.r.l. 286
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 282
Protein corona and nanoparticles: How can we investigate on? 268
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 264
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 264
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 253
Nanoparticle transport across the blood brain barrier 250
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 249
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 249
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 246
Distribution of drugs in polymers loaded by swelling 245
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 245
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 244
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 243
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 242
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 240
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 239
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 237
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 237
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 237
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 236
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 230
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 229
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 227
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 227
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 226
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 224
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 222
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 220
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 219
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 218
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 218
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 217
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 217
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 216
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 213
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 213
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 213
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 212
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 212
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 211
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 211
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 211
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 210
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 209
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 209
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 208
Functionalization of liposomes: microscopical methods for preformulative screening 208
Colloidal systems for CNS drug delivery 204
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 204
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 203
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 203
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 203
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 202
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 202
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 201
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 201
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 200
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 199
Proprietà fisiche e disponibilità del cloramfenicolo palmitato in miscele macinate con cellulosa microcristallina 198
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 197
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 196
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 195
Effect of the loading method on the drug release from cross-linked carboxymethylcellulose beads 195
EFFECT OF MONTMORILLONITE ON DRUG RELEASE FROM POLYMERIC MATRICES 194
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 194
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 194
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 194
Cationic liposomes for gene transfection 193
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 193
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 193
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 192
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 192
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 192
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 190
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 189
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 189
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 189
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 189
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 188
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 187
Preparazione e caratterizzazione del complesso tra acido iodesossicolico e 2-idrossipropil-beta-ciclodestrina 186
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 185
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 185
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 185
Solfadiazina: microincapsulazione e studio del rilascio 184
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 184
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 184
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 183
Polymeric nanoparticles for the drug delivery to the central nervous system 182
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 182
Ketorolac tromethamine liposomes: Encapsulation and release studies 179
Nanomedicine and neurodegenerative disorders: So close yet so far 176
Totale 22.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 180.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.054
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.508 0 0 0 0 0 0 1.413 922 927 334 532 380
2020/20217.376 1.077 297 521 661 712 432 629 867 320 1.076 442 342
2021/20225.275 221 631 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/20256.708 647 183 264 943 2.567 1.738 366 0 0 0 0 0
Totale 46.611